Earnings Per Share, Diluted of Arch Therapeutics, Inc. from 30 Jun 2013 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Arch Therapeutics, Inc. quarterly and annual Earnings Per Share, Diluted in USD/shares history and change rate from 30 Jun 2013 to 30 Jun 2024.
  • Arch Therapeutics, Inc. Earnings Per Share, Diluted for the quarter ending 30 Jun 2024 was -1.44, a 1.4% decline year-over-year.
  • Arch Therapeutics, Inc. annual Earnings Per Share, Diluted for 2021 was -0.03, a 50% decline from 2020.
Source SEC data
View on sec.gov
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)

Arch Therapeutics, Inc. Quarterly Earnings Per Share, Diluted (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 -1.44 -0.02 -1.4% 01 Apr 2024 30 Jun 2024 10-Q 19 Aug 2024 2024 Q3
Q2 2023 -1.42 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024 2024 Q3
Q1 2020 0 0 01 Jan 2020 31 Mar 2020 10-Q 05 May 2020 2020 Q2
Q1 2019 0 +0.01 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020 2020 Q2
Q4 2018 -0.02 -0.02 01 Oct 2018 31 Dec 2018 10-Q 01 Feb 2019 2019 Q1
Q1 2018 -0.01 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q2
Q4 2017 0 +0.01 01 Oct 2017 31 Dec 2017 10-Q 01 Feb 2019 2019 Q1
Q4 2016 -0.01 0 0% 01 Oct 2016 31 Dec 2016 10-Q 01 Feb 2018 2018 Q1
Q4 2015 -0.01 -0.02 -200% 01 Oct 2015 31 Dec 2015 10-Q 12 Feb 2016 2016 Q1
Q2 2015 -0.02 -0.03 -300% 01 Apr 2015 30 Jun 2015 10-Q 07 Aug 2015 2015 Q3
Q4 2014 0.01 +0.02 01 Oct 2014 31 Dec 2014 10-Q 12 Feb 2016 2016 Q1
Q2 2014 0.01 +0.07 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015 2015 Q3
Q4 2013 -0.01 01 Oct 2013 31 Dec 2013 10-Q 09 Feb 2015 2015 Q1
Q2 2013 -0.06 01 Apr 2013 30 Jun 2013 10-Q 06 Aug 2014 2014 Q3

Arch Therapeutics, Inc. Annual Earnings Per Share, Diluted (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2021 -0.03 -0.01 -50% 01 Oct 2020 30 Sep 2021 10-K 17 Dec 2021 2021 FY
2020 -0.02 01 Oct 2019 30 Sep 2020 10-K 17 Dec 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.